Transient Receptor Potential Ankyrin 1 Ion Channel Is Expressed in Osteosarcoma and Its Activation Reduces Viability

Area of Science:

• Oncology
• Molecular Biology
• Ion Channel Physiology

Background:

• Osteosarcoma is a malignant bone cancer with limited treatment options and poor prognosis.
• Transient Receptor Potential Ankyrin 1 (TRPA1) and Vanilloid 1 (TRPV1) are ion channels implicated in various cancers.
• Their role in osteosarcoma pathogenesis and potential as therapeutic targets remains largely unexplored.

Purpose of the Study:

• To characterize the expression and functionality of TRPA1 and TRPV1 channels in human and mouse osteosarcoma.
• To investigate the impact of TRPA1 and TRPV1 activation on osteosarcoma cell viability.
• To explore potential diagnostic and therapeutic applications of these ion channels in osteosarcoma.

Main Methods:

• Quantitative PCR and RNAscope in situ hybridization for TRPA1/Trpa1 and TRPV1/Trpv1 mRNA expression analysis.
• Radioactive 45Ca2+ uptake assays to assess channel functionality upon agonist stimulation (AITC for TRPA1, capsaicin for TRPV1).
• Cell viability assays (luminescence) to determine the effects of agonists and antagonists on K7M2 osteosarcoma cells.

Main Results:

• TRPA1 and TRPV1 mRNA were expressed in human and mouse osteosarcoma tissues; Trpa1 was more abundant in K7M2 cells.
• TRPA1 activation by AITC significantly increased 45Ca2+ influx and reduced K7M2 cell viability (EC50 = 22 µM).
• TRPV1 activation by capsaicin showed a moderate, non-significant calcium influx and reduced cell viability (EC50 = 74 µM); effects were partially antagonized.

Conclusions:

• This study provides the first evidence for functional expression of TRPA1 and TRPV1 ion channels in osteosarcoma.
• TRPA1 activation demonstrates significant cytotoxic effects on osteosarcoma cells, indicating its potential as a therapeutic target.
• These findings suggest novel diagnostic and therapeutic strategies for osteosarcoma targeting TRPA1 and TRPV1 channels.